Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: a consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians.

Abstract

The aim of this article is to inform about cancer treatment-induced bone loss, to identify patients at risk and those that can benefit from bone targeted treatment as well as highlight the importance of the multidisciplinary approach in the bone health in cancer care. Patients with breast cancer treated or intended to be treated with aromatase inhibitors… (More)
DOI: 10.1016/j.medici.2014.09.004

Topics

Cite this paper

@article{Juozaityt2014GuidelinesFD, title={Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: a consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians.}, author={Elona Juozaitytė and Eduardas Aleknavi{\vc}ius and Rasa Jan{\vc}iauskienė and Alvydas {\vC}esas and Teresė Pipirienė-Želvienė and Sigita Liutkauskienė and Aurelija Krasauskienė and Lina Vencevi{\vc}ienė}, journal={Medicina}, year={2014}, volume={50 4}, pages={197-203} }